TY - JOUR
T1 - Multiple low-affinity interactions support binding of human osteopontin to integrin αxβ2
AU - Kläning, Eva
AU - Christensen, Brian
AU - Bajic, Goran
AU - Hoffmann, Søren V.
AU - Jones, Nykola C.
AU - Callesen, Morten M.
AU - Andersen, Gregers R.
AU - Sørensen, Esben S.
AU - Vorup-Jensen, Thomas
N1 - Publisher Copyright:
© 2015 Elsevier B.V.
PY - 2015/4/18
Y1 - 2015/4/18
N2 - Integrin αXβ2 (also known as complement receptor 4, p150,95, or CD11c/CD18) is expressed in the cell membrane of myeloid leukocytes. αXβ2 has been reported to bind a large number of structurally unrelated ligands, often with a shared molecular character in the presence of polyanionic stretches in poorly folded proteins or glucosaminoglycans. Nevertheless, it is unclear what chemical sources of polyanionicity enable the binding by αXβ2. Osteopontin (OPN) is an intrinsically disordered protein, which facilitates phagocytosis via the integrin αXβ2. Unlike for other integrins, neither the RGD nor the SVVYGLR motifs account for this binding, and the molecular basis of OPN binding by αXβ2 remains uncharacterized. Here, we show that the monovalent interactions between the ligand-binding domain of αXβ2 and OPN, its fragments, or caseins are weak, with dissociation constants higher than 10- 5 M but with high apparent stoichiometries. From comparison with cell adhesion studies, the discrimination between αXβ2 ligands and non-ligands appears to rely on these apparent stoichiometries in a way, which involves glutamate rather than aspartate side chains. Surprisingly, the extensive, negatively charged phosphorylation of OPN is not contributing to αXβ2 binding. Furthermore, synchrotron radiation circular spectroscopy excludes that the phosphorylation affects the general folding of OPN. Taken together, our quantitative analyses reveal a mode of ligand recognition by integrin αXβ2, which seem to differ in principles considerably from other OPN receptors.
AB - Integrin αXβ2 (also known as complement receptor 4, p150,95, or CD11c/CD18) is expressed in the cell membrane of myeloid leukocytes. αXβ2 has been reported to bind a large number of structurally unrelated ligands, often with a shared molecular character in the presence of polyanionic stretches in poorly folded proteins or glucosaminoglycans. Nevertheless, it is unclear what chemical sources of polyanionicity enable the binding by αXβ2. Osteopontin (OPN) is an intrinsically disordered protein, which facilitates phagocytosis via the integrin αXβ2. Unlike for other integrins, neither the RGD nor the SVVYGLR motifs account for this binding, and the molecular basis of OPN binding by αXβ2 remains uncharacterized. Here, we show that the monovalent interactions between the ligand-binding domain of αXβ2 and OPN, its fragments, or caseins are weak, with dissociation constants higher than 10- 5 M but with high apparent stoichiometries. From comparison with cell adhesion studies, the discrimination between αXβ2 ligands and non-ligands appears to rely on these apparent stoichiometries in a way, which involves glutamate rather than aspartate side chains. Surprisingly, the extensive, negatively charged phosphorylation of OPN is not contributing to αXβ2 binding. Furthermore, synchrotron radiation circular spectroscopy excludes that the phosphorylation affects the general folding of OPN. Taken together, our quantitative analyses reveal a mode of ligand recognition by integrin αXβ2, which seem to differ in principles considerably from other OPN receptors.
KW - Cell adhesion
KW - Integrin
KW - Integrin I domain
KW - Osteopontin
KW - Phosphorylation
KW - Surface plasmon resonance
UR - http://www.scopus.com/inward/record.url?scp=84928901877&partnerID=8YFLogxK
U2 - 10.1016/j.bbapap.2015.03.008
DO - 10.1016/j.bbapap.2015.03.008
M3 - Article
C2 - 25839998
AN - SCOPUS:84928901877
SN - 1570-9639
VL - 1854
SP - 930
EP - 938
JO - Biochimica et Biophysica Acta - Proteins and Proteomics
JF - Biochimica et Biophysica Acta - Proteins and Proteomics
IS - 8
ER -